Funding

Lamark Biotech Raises ₹6.5 Cr in Pre-Series A Round to Advance Thermostable Insulin Innovation

Published

on

[ad_1]

Funding Alert

Ahmedabad-based biopharma startup Lamark Biotech has raised ₹6.5 crore in a pre-Series A funding round led by the IAN Group, including contributions from IAN Alpha Fund, BioAngels, and prominent angel investors such as Vinayender Tulla, Nita Roy, and Venkataraman…

[ad_2]

Source link

You must be logged in to post a comment Login

Leave a Reply

Cancel reply

Exit mobile version